The Benefits of Restorative Programming for Skilled Nursing Facilities 
Hemostemix’s Boots on the Ground in Florida
Calgary, Alberta--(Newsfile Corp. - August 26, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), an autologous (patient's own)...
Red Light Holland Updates Bitcoin Balance Sheet Strategy
Purchases of iShares Bitcoin ETF (IBIT) and Progress Toward Arch Public IntegrationToronto, Ontario--(Newsfile Corp. - August 26, 2025) - Red...
National Psoriasis Foundation Awards Seal of Recognition to Sonoma Pharmaceuticals for Reliefacyn Advanced
BOULDER, CO / ACCESS Newswire / August 26, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and...
DrHouse Launches Florida’s First Telehealth Service With Free On-Demand Prescription Delivery
From diagnosis to doorstep: DrHouse launches the first end-to-end telehealth app in Florida, from doctor visit to complimentary 1-hour prescription...
PA Health & Wellness Partners With Vheda Health to Advance Virtual Care for Participants With Chronic Conditions
MECHANICSBURG, PENNSYLVANIA / ACCESS Newswire / August 26, 2025 / PA Health & Wellness, a company of Centene Corporation, has...
AMC Health Expands Virtual Care Offering to Boost HEDIS & Star Ratings for Health Plans
Building on more than 20 years of data and expertise, AMC Health announces a major expansion of its virtual care...
Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025
LAVAL, QC AND CUPERTINO, CA / ACCESS Newswire / August 26, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global,...
Modular Medical Announces Completion of MODD1 Cartridge Production and Commencement of Pivot Conversion
-More than 6,000 MODD1 cartridges produced- Conversion to Pivot-ready manufacturing in preparation for product launch in 1Q26 SAN DIEGO, CA...
Hemogenyx raises £570,000 and Director’s Dealing
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS...
Omada Health to Participate in Upcoming Investor Conference
SAN FRANCISCO, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that...
FAMU College of Pharmacy Alumnus and Industry Pioneer Stan Loomis Inducted into Gallery of Distinction and Keynoted the 2025 White Coat Ceremony
Pharmacy Leader and FAMU Alumnus Stan Loomis Received Top Honor, Inspire Future Pharmacists as Keynote SpeakerORLANDO, Fla., Aug. 26, 2025...
Dr. Shai Efrati Honored With 2025 Ellis Island Medal of Honor
Hyperbaric oxygen therapy pioneer and Aviv Clinics medical advisor honored for research and service to veterans and patients with stroke,...
PolarityBio Completes Enrollment in the Phase III Pivotal Study of SkinTE for Diabetic Foot Ulcers
SALT LAKE CITY, Aug. 26, 2025 (GLOBE NEWSWIRE) -- PolarityBio, a clinical-stage biotechnology company focused on addressing unmet needs in...
Odyssey Health, Inc. to Advance Development of its Save A Life Choking Rescue Device
Company to Advance Development of its Patented DeviceLAS VEGAS, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTCQB: ODYY)...
CDT Equity Identifies New Biological Target Validating AI-Driven Repurposing Strategy
Using AI, CDT Equity Inc. identifies a novel therapeutic indication for its lead programmes, supported by successful pre-clinical trial dataNAPLES,...
Adagene to Participate in Two Investor Conferences in September
SAN DIEGO and SUZHOU, China, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene or the Company”) (Nasdaq: ADAG), a company...
Clearside Biomedical Announces Multiple Presentations on Suprachoroidal Delivery to be Featured at the 25th EURETINA Congress
- Presentations Highlight the Versatility of Clearside’s SCS Microinjector® Platform for the Treatment of Multiple Retinal Diseases - - CLS-AX...
Compass Therapeutics to Participate in Upcoming September Investor Events
BOSTON, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (“Compass”) (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary...
Ashvattha Therapeutics to Present Late-Breaking Phase 2 DME and nAMD Data at 25th EURETINA Congress
Company to present topline 40-week Phase 2 study efficacy and safety results of migaldendranib (MGB), a novel first-in-class nanomedicine for...
Fulcrum Therapeutics to Present at Upcoming Investor Meetings
CAMBRIDGE, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused...